{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:57:38Z","timestamp":1785585458662,"version":"3.56.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06091-5","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:32:22Z","timestamp":1785583942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Mitochondrial Dysfunction in Microglia: A New Frontier for Treating Neurodegenerative Diseases"],"prefix":"10.1007","volume":"63","author":[{"given":"Mengqi","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"5580","key":"6091_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"issue":"4","key":"6091_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"6645","key":"6091_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388(6645):839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"issue":"6","key":"6091_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00429-025-02959-9","volume":"230","author":"A Vaquero-Rodr\u00edguez","year":"2025","unstructured":"Vaquero-Rodr\u00edguez A, Razquin J, Murueta-Goyena A, Miguelez C, Ru\u00edz-Ortega J\u00c1, Lafuente JV et al (2025) Temporal progression of pathological features in an \u03b1-synuclein overexpression model of Parkinson\u2019s disease. Brain Struct Funct 230(6):91. https:\/\/doi.org\/10.1007\/s00429-025-02959-9","journal-title":"Brain Struct Funct"},{"issue":"5796","key":"6091_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u20133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"issue":"6415","key":"6091_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59\u201362. https:\/\/doi.org\/10.1038\/362059a0","journal-title":"Nature"},{"issue":"9","key":"6091_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.it.2020.07.006","volume":"41","author":"SA Liddelow","year":"2020","unstructured":"Liddelow SA, Marsh SE, Stevens B (2020) Microglia and astrocytes in disease: dynamic duo or partners in crime? Trends Immunol 41(9):820\u2013835. https:\/\/doi.org\/10.1016\/j.it.2020.07.006","journal-title":"Trends Immunol"},{"issue":"1","key":"6091_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"issue":"18","key":"6091_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW et al (2021) Donanemab in Early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"issue":"6","key":"6091_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jama.2023.11704","volume":"330","author":"JJ Manly","year":"2023","unstructured":"Manly JJ, Deters KD (2023) Donanemab for Alzheimer disease-who benefits and who is harmed? JAMA 330(6):510\u2013511. https:\/\/doi.org\/10.1001\/jama.2023.11704","journal-title":"JAMA"},{"issue":"1","key":"6091_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-w","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39(1):151\u2013170. https:\/\/doi.org\/10.1016\/0306-4522(90)90229-w","journal-title":"Neuroscience"},{"key":"6091_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"6091_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"6091_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS et al (2020) Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23(2):194\u2013208. https:\/\/doi.org\/10.1038\/s41593-019-0566-1","journal-title":"Nat Neurosci"},{"issue":"4","key":"6091_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I et al (2019) The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep 27(4):1293-1306.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099","journal-title":"Cell Rep"},{"issue":"3","key":"6091_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R et al (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566-581.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"issue":"4","key":"6091_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10(4):217\u2013224. https:\/\/doi.org\/10.1038\/nrneurol.2014.38","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"6091_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"6286","key":"6091_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S et al (2016) Complement and microglia mediate early synaptic loss in Alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"6091_CR20","unstructured":"Bilbo S, Stevens B (2017) Microglia: the brain\u2019s first responders. Cerebrum 2017:cer-14\u201317"},{"key":"6091_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07300-0","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB et al (2024) Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628:195\u2013203. https:\/\/doi.org\/10.1038\/s41586-024-07300-0","journal-title":"Nature"},{"issue":"4","key":"6091_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL et al (2017) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170(4):649\u201363.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023","journal-title":"Cell"},{"key":"6091_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102846","volume":"66","author":"M Sangineto","year":"2023","unstructured":"Sangineto M, Ciarnelli M, Cassano T, Radesco A, Moola A, Bukke VN et al (2023) Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer\u2019s disease. Redox Biol 66. https:\/\/doi.org\/10.1016\/j.redox.2023.102846","journal-title":"Redox Biol"},{"issue":"1","key":"6091_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0305-9","volume":"14","author":"L Wang","year":"2019","unstructured":"Wang L, Pavlou S, Du X, Bhuckory M, Xu H, Chen M (2019) Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener 14(1). https:\/\/doi.org\/10.1186\/s13024-019-0305-9","journal-title":"Mol Neurodegener"},{"key":"6091_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113310","volume":"329","author":"NA Devanney","year":"2020","unstructured":"Devanney NA, Stewart AN, Gensel JC (2020) Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol 329. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113310","journal-title":"Exp Neurol"},{"issue":"8","key":"6091_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209177120","volume":"120","author":"LH Fairley","year":"2023","unstructured":"Fairley LH, Lai KO, Wong JH, Chong WJ, Vincent AS, D\u2019Agostino G et al (2023) Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 120(8). https:\/\/doi.org\/10.1073\/pnas.2209177120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"6091_CR27","doi-asserted-by":"publisher","first-page":"15724","DOI":"10.1021\/acsnano.3c03232","volume":"17","author":"F Yang","year":"2023","unstructured":"Yang F, Zhao D, Cheng M, Liu Y, Chen Z, Chang J et al (2023) mTOR-mediated immunometabolic reprogramming nanomodulators enable sensitive switching of energy deprivation-induced microglial polarization for Alzheimer\u2019s disease management. ACS Nano 17(16):15724\u201315741. https:\/\/doi.org\/10.1021\/acsnano.3c03232","journal-title":"ACS Nano"},{"issue":"3","key":"6091_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.14336\/AD.2023.0807","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F (2024) Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation. Aging Dis 15(3):1155\u20131175. https:\/\/doi.org\/10.14336\/AD.2023.0807","journal-title":"Aging Dis"},{"key":"6091_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-021-03237-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas PS, Latif-Hernandez A, McReynolds MR, Durairaj AS, Wang Q, Rubin A et al (2021) Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590:122\u2013128. https:\/\/doi.org\/10.1038\/s41586-021-03237-0","journal-title":"Nature"},{"issue":"4","key":"6091_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J et al (2022) Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab 34(4):634-648.e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.013","journal-title":"Cell Metab"},{"key":"6091_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116342","volume":"173","author":"Q Ruan","year":"2024","unstructured":"Ruan Q, Geng Y, Zhao M, Zhang H, Cheng X, Zhao T et al (2024) Prolyl hydroxylase inhibitor FG-4592 alleviates neuroinflammation via HIF-1\/BNIP3 signaling in microglia. Biomed Pharmacother 173. https:\/\/doi.org\/10.1016\/j.biopha.2024.116342","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"6091_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE et al (2016) Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167(2):457-470.e13. https:\/\/doi.org\/10.1016\/j.cell.2016.08.064","journal-title":"Cell"},{"key":"6091_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102545","volume":"102","author":"R Thapa","year":"2024","unstructured":"Thapa R, Moglad E, Afzal M, Gupta G, Bhat AA, Hassan Almalki W et al (2024) The role of sirtuin 1 in ageing and neurodegenerative disease: a molecular perspective. Ageing Res Rev 102. https:\/\/doi.org\/10.1016\/j.arr.2024.102545","journal-title":"Ageing Res Rev"},{"issue":"R2","key":"6091_CR34","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","volume":"18","author":"H Chen","year":"2009","unstructured":"Chen H, Chan DC (2009) Mitochondrial dynamics\u2014fusion, fission, movement, and mitophagy\u2014in neurodegenerative diseases. Hum Mol Genet 18(R2):R169\u2013R176. https:\/\/doi.org\/10.1093\/hmg\/ddp326","journal-title":"Hum Mol Genet"},{"issue":"9","key":"6091_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI et al (2022) Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci 25(9):1134\u20131148. https:\/\/doi.org\/10.1038\/s41593-022-01140-3","journal-title":"Nat Neurosci"},{"issue":"11","key":"6091_CR36","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/j.bbamcr.2016.09.003","volume":"1863","author":"DI Kim","year":"2016","unstructured":"Kim DI, Lee KH, Gabr AA, Choi GE, Kim JS, Ko SH et al (2016) A\u03b2-induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Biochimica et Biophysica Acta (BBA) 1863(11):2820\u20132834. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.003","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"6091_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1471-4159.2011.07329.x","volume":"118","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired dynamics of Drp1 and mitochondrial fusion in Alzheimer\u2019s disease models. J Neurochem 118(3):413\u2013429. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07329.x","journal-title":"J Neurochem"},{"issue":"23","key":"6091_CR38","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"MJ Calkins","year":"2011","unstructured":"Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 20(23):4515\u20134529. https:\/\/doi.org\/10.1093\/hmg\/ddr381","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6091_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141(1):39\u201365. https:\/\/doi.org\/10.1007\/s00401-020-02234-7","journal-title":"Acta Neuropathol"},{"key":"6091_CR40","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41593-019-0486-z","volume":"22","author":"AU Joshi","year":"2019","unstructured":"Joshi AU, Minhas PS, Liddelow SA, Haileselassie B, Andreasson KI, Dorn GW 2nd et al (2019) Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci 22:1635\u20131648. https:\/\/doi.org\/10.1038\/s41593-019-0486-z","journal-title":"Nat Neurosci"},{"issue":"4","key":"6091_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305442","volume":"11","author":"FL Wei","year":"2024","unstructured":"Wei FL, Wang TF, Wang CL, Zhang ZP, Zhao JW, Heng W et al (2024) Cytoplasmic escape of mitochondrial DNA mediated by Mfn2 downregulation promotes microglial activation via cGas-Sting axis in spinal cord injury. Adv Sci (Weinh) 11(4). https:\/\/doi.org\/10.1002\/advs.202305442","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"6091_CR42","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.76480","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L (2023) Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics 13(2):736\u2013766. https:\/\/doi.org\/10.7150\/thno.76480","journal-title":"Theranostics"},{"issue":"1","key":"6091_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J et al (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8(1). https:\/\/doi.org\/10.1371\/journal.pbio.1000298","journal-title":"PLoS Biol"},{"issue":"7565","key":"6091_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL et al (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524(7565):309\u2013314. https:\/\/doi.org\/10.1038\/nature14893","journal-title":"Nature"},{"issue":"10","key":"6091_CR45","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ (2024) The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol 26(10):1639\u20131651. https:\/\/doi.org\/10.1038\/s41556-024-01513-9","journal-title":"Nat Cell Biol"},{"key":"6091_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00120","volume":"10","author":"F Mouton-Liger","year":"2017","unstructured":"Mouton-Liger F, Jacoupy M, Corvol JC, Corti O (2017) PINK1\/Parkin-dependent mitochondrial surveillance: from pleiotropy to Parkinson\u2019s disease. Front Mol Neurosci 10. https:\/\/doi.org\/10.3389\/fnmol.2017.00120","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"6091_CR47","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.1909814117","volume":"117","author":"SJ Ham","year":"2020","unstructured":"Ham SJ, Lee D, Yoo H, Jun K, Shin H, Chung J (2020) Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination. Proc Natl Acad Sci U S A 117(8):4281\u20134291. https:\/\/doi.org\/10.1073\/pnas.1909814117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6091_CR48","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.immuni.2025.04.029","volume":"58","author":"P Prakash","year":"2025","unstructured":"Prakash P, Manchanda P, Paouri E, Bisht K, Sharma K, Rajpoot J et al (2025) Amyloid-\u03b2 induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer\u2019s disease. Immunity 58(6):1536\u201352.e8. https:\/\/doi.org\/10.1016\/j.immuni.2025.04.029","journal-title":"Immunity"},{"issue":"1","key":"6091_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes C, Danhash EP, Hasselmann J, Chadarevian JP, Shabestari SK, England WE et al (2021) Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol Neurodegener 16(1). https:\/\/doi.org\/10.1186\/s13024-021-00473-0","journal-title":"Mol Neurodegener"},{"issue":"5","key":"6091_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050863","volume":"13","author":"K Maksimovic","year":"2023","unstructured":"Maksimovic K, Youssef M, You J, Sung HK, Park J (2023) Evidence of metabolic dysfunction in amyotrophic lateral sclerosis (ALS) patients and animal models. Biomolecules 13(5). https:\/\/doi.org\/10.3390\/biom13050863","journal-title":"Biomolecules"},{"issue":"1","key":"6091_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","volume":"11","author":"TW Tefera","year":"2021","unstructured":"Tefera TW, Steyn FJ, Ngo ST, Borges K (2021) CNS glucose metabolism in amyotrophic lateral sclerosis: a therapeutic target? Cell Biosci 11(1):14. https:\/\/doi.org\/10.1186\/s13578-020-00511-2","journal-title":"Cell Biosci"},{"key":"6091_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107133","volume":"216","author":"A Ajoolabady","year":"2025","unstructured":"Ajoolabady A, Kim B, Abdulkhaliq AA, Ren J, Bahijri S, Tuomilehto J et al (2025) Dual role of microglia in neuroinflammation and neurodegenerative diseases. Neurobiol Dis 216. https:\/\/doi.org\/10.1016\/j.nbd.2025.107133","journal-title":"Neurobiol Dis"},{"issue":"622","key":"6091_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe3947","volume":"13","author":"FA Sayed","year":"2021","unstructured":"Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D et al (2021) AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci Transl Med 13(622). https:\/\/doi.org\/10.1126\/scitranslmed.abe3947","journal-title":"Sci Transl Med"},{"issue":"Pt 2","key":"6091_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113446","volume":"143","author":"S Yin","year":"2024","unstructured":"Yin S, Chi X, Wan F, Li Y, Zhou Q, Kou L et al (2024) TREM2 signaling in Parkinson\u2019s disease: regulation of microglial function and \u03b1-synuclein pathology. Int Immunopharmacol 143(Pt 2). https:\/\/doi.org\/10.1016\/j.intimp.2024.113446","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"6091_CR55","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"MM Lin","year":"2022","unstructured":"Lin MM, Liu N, Qin ZH, Wang Y (2022) Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 43(10):2439\u20132447. https:\/\/doi.org\/10.1038\/s41401-022-00879-6","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"6091_CR56","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","volume":"71","author":"J Cady","year":"2014","unstructured":"Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P et al (2014) TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71(4):449\u2013453. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6237","journal-title":"JAMA Neurol"},{"issue":"3","key":"6091_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115403","volume":"44","author":"J Xu","year":"2025","unstructured":"Xu J, Wakai M, Xiong K, Yang Y, Prabakaran A, Wu S et al (2025) The pro-inflammatory cytokine IL6 suppresses mitochondrial function via the gp130-JAK1\/STAT1\/3-HIF1\u03b1\/ERR\u03b1 axis. Cell Rep 44(3). https:\/\/doi.org\/10.1016\/j.celrep.2025.115403","journal-title":"Cell Rep"},{"issue":"1","key":"6091_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","volume":"4","author":"A Sarapultsev","year":"2023","unstructured":"Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D (2023) JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions. Mol Biomed 4(1):40. https:\/\/doi.org\/10.1186\/s43556-023-00151-1","journal-title":"Mol Biomed"},{"issue":"10","key":"6091_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100680","volume":"14","author":"EM Verde","year":"2025","unstructured":"Verde EM, Secco V, Ghezzi A, Mandrioli J, Carra S (2025) Molecular mechanisms of protein aggregation in ALS-FTD: focus on TDP-43 and cellular protective responses. Cells 14(10). https:\/\/doi.org\/10.3390\/cells14100680","journal-title":"Cells"},{"key":"6091_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12. https:\/\/doi.org\/10.3389\/fnmol.2019.00025","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"6091_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03165-7","volume":"11","author":"MH Jun","year":"2020","unstructured":"Jun MH, Jang JW, Jeon P, Lee SK, Lee SH, Choi HE et al (2020) Nonmuscle myosin IIB regulates Parkin-mediated mitophagy associated with amyotrophic lateral sclerosis-linked TDP-43. Cell Death Dis 11(11). https:\/\/doi.org\/10.1038\/s41419-020-03165-7","journal-title":"Cell Death Dis"},{"issue":"1","key":"6091_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics 21(1). https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","journal-title":"Neurotherapeutics"},{"issue":"3","key":"6091_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B et al (2019) Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412. https:\/\/doi.org\/10.1038\/s41593-018-0332-9","journal-title":"Nat Neurosci"},{"issue":"10","key":"6091_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101208","volume":"13","author":"H Fanlo-Ucar","year":"2024","unstructured":"Fanlo-Ucar H, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, Ill-Raga G, Mu\u00f1oz FJ (2024) The dual role of amyloid beta-peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer\u2019s disease etiopathology. Antioxidants (Basel) 13(10). https:\/\/doi.org\/10.3390\/antiox13101208","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"6091_CR65","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.110012","volume":"1","author":"HI Woodroof","year":"2011","unstructured":"Woodroof HI, Pogson JH, Begley M, Cantley LC, Deak M, Campbell DG et al (2011) Discovery of catalytically active orthologues of the Parkinson\u2019s disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biol 1(3). https:\/\/doi.org\/10.1098\/rsob.110012","journal-title":"Open Biol"},{"issue":"1","key":"6091_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01714-w","volume":"17","author":"H Chen","year":"2025","unstructured":"Chen H, Li N, Liu N, Zhu H, Ma C, Ye Y et al (2025) Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP\/PS1 mouse model of Alzheimer\u2019s disease. Alzheimers Res Ther 17(1). https:\/\/doi.org\/10.1186\/s13195-025-01714-w","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"6091_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00824-1","volume":"20","author":"M Slayo","year":"2025","unstructured":"Slayo M, Rummel C, Singhaarachchi PH, Feldotto M, Spencer SJ (2025) The role of n-3-derived specialised pro-resolving mediators (SPMs) in microglial mitochondrial respiration and inflammation resolution in Alzheimer\u2019s disease. Mol Neurodegener 20(1). https:\/\/doi.org\/10.1186\/s13024-025-00824-1","journal-title":"Mol Neurodegener"},{"issue":"18","key":"6091_CR68","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","volume":"112","author":"H Scheiblich","year":"2024","unstructured":"Scheiblich H, Eikens F, Wischhof L, Opitz S, J\u00fcngling K, Cser\u00e9p C et al (2024) Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes. Neuron 112(18):3106-3125.e8. https:\/\/doi.org\/10.1016\/j.neuron.2024.06.029","journal-title":"Neuron"},{"issue":"6","key":"6091_CR69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17(6):363\u2013375. https:\/\/doi.org\/10.1038\/nri.2017.21","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"6091_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121917","volume":"10","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu B, Xu L, Yu S, Fu J, Wang J et al (2021) ROS-induced mtDNA release: the emerging messenger for communication between neurons and innate immune cells during neurodegenerative disorder progression. Antioxidants (Basel) 10(12). https:\/\/doi.org\/10.3390\/antiox10121917","journal-title":"Antioxidants (Basel)"},{"issue":"7973","key":"6091_CR71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gl\u00fcck S et al (2023) cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620(7973):374\u2013380. https:\/\/doi.org\/10.1038\/s41586-023-06373-1","journal-title":"Nature"},{"key":"6091_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.009","volume":"548","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang B, Duan R, Liu Y (2024) Mitochondrial DNA leakage and cGas\/STING pathway in microglia: crosstalk between neuroinflammation and neurodegeneration. Neuroscience 548:1\u20138. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.04.009","journal-title":"Neuroscience"},{"key":"6091_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109977","volume":"37","author":"J Willemsen","year":"2021","unstructured":"Willemsen J, Neuhoff MT, Hoyler T, Noir E, Tessier C, Sarret S et al (2021) TNF leads to MtDNA release and cGAS\/STING-dependent interferon responses that support inflammatory arthritis. Cell Rep 37. https:\/\/doi.org\/10.1016\/j.celrep.2021.109977","journal-title":"Cell Rep"},{"key":"6091_CR74","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1172\/JCI134560","volume":"130","author":"A Jauhari","year":"2020","unstructured":"Jauhari A, Baranov SV, Suofu Y, Kim J, Singh T, Yablonska S et al (2020) Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J Clin Invest 130:3124\u20133136. https:\/\/doi.org\/10.1172\/JCI134560","journal-title":"J Clin Invest"},{"key":"6091_CR75","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10571-017-0495-1","volume":"37","author":"CB Pointer","year":"2017","unstructured":"Pointer CB, Klegeris A (2017) Cardiolipin in central nervous system physiology and pathology. Cell Mol Neurobiol 37:1161\u20131172. https:\/\/doi.org\/10.1007\/s10571-017-0495-1","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"6091_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26851-2","volume":"12","author":"M Jin","year":"2021","unstructured":"Jin M, Shiwaku H, Tanaka H, Obita T, Ohuchi S, Yoshioka Y et al (2021) Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat Commun 12(1). https:\/\/doi.org\/10.1038\/s41467-021-26851-2","journal-title":"Nat Commun"},{"issue":"3","key":"6091_CR77","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"CH Yu","year":"2020","unstructured":"Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P et al (2020) TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell 183(3):636\u201349.e18. https:\/\/doi.org\/10.1016\/j.cell.2020.09.020","journal-title":"Cell"},{"key":"6091_CR78","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4050796","author":"E Bajwa","year":"2019","unstructured":"Bajwa E, Pointer CB, Klegeris A (2019) The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2019\/4050796","journal-title":"Mediators Inflamm"},{"issue":"15","key":"6091_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152364","volume":"11","author":"CM Deus","year":"2022","unstructured":"Deus CM, Tavares H, Beatriz M, Mota S, Lopes C (2022) Mitochondrial damage-associated molecular patterns content in extracellular vesicles promotes early inflammation in neurodegenerative disorders. Cells 11(15). https:\/\/doi.org\/10.3390\/cells11152364","journal-title":"Cells"},{"issue":"10","key":"6091_CR80","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41594-025-01602-9","volume":"32","author":"G Miao","year":"2025","unstructured":"Miao G, Fortier TM, Liu H, Schafer DP, Fitzgerald KA, Mao J et al (2025) Microglia promote inflammatory cell death upon neuronal mitochondrial impairment during neurodegeneration. Nat Struct Mol Biol 32(10):2046\u20132059. https:\/\/doi.org\/10.1038\/s41594-025-01602-9","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"6091_CR81","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","volume":"28","author":"E Tresse","year":"2023","unstructured":"Tresse E, Marturia-Navarro J, Sew WQG, Cisquella-Serra M, Jaberi E, Riera-Ponsati L et al (2023) Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology. Mol Psychiatry 28(11):4902\u20134914. https:\/\/doi.org\/10.1038\/s41380-023-02251-4","journal-title":"Mol Psychiatry"},{"issue":"1","key":"6091_CR82","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, Xia X, Wang Y, Zheng JC (2022) Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease. J Neuroinflammation 19(1):248. https:\/\/doi.org\/10.1186\/s12974-022-02613-9","journal-title":"J Neuroinflammation"},{"key":"6091_CR83","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2025.06.021","volume":"129","author":"G Risby-Jones","year":"2025","unstructured":"Risby-Jones G, Marallag J, Jagaraj CJ, Atkin JD, Walker AK, Woodruff TM et al (2025) IL-6 trans-signalling is elevated in ALS models and drives TDP-43 induced inflammatory responses in microglia. Brain Behav Immun 129:296\u2013304. https:\/\/doi.org\/10.1016\/j.bbi.2025.06.021","journal-title":"Brain Behav Immun"},{"issue":"6","key":"6091_CR84","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1007\/s12035-025-04758-z","volume":"62","author":"G Ayyubova","year":"2025","unstructured":"Ayyubova G, Madhu LN (2025) Microglial NLRP3 inflammasomes in Alzheimer\u2019s disease pathogenesis: from interaction with autophagy\/mitophagy to therapeutics. Mol Neurobiol 62(6):7124\u20137143. https:\/\/doi.org\/10.1007\/s12035-025-04758-z","journal-title":"Mol Neurobiol"},{"key":"6091_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S, Buttari B, Profumo E, Tucci P, Saso L (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15. https:\/\/doi.org\/10.3389\/fncel.2021.787258","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"6091_CR86","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20021546","volume":"197","author":"JB El Khoury","year":"2003","unstructured":"El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, Toft M et al (2003) CD36 mediates the innate host response to beta-amyloid. J Exp Med 197(12):1657\u20131666. https:\/\/doi.org\/10.1084\/jem.20021546","journal-title":"J Exp Med"},{"issue":"1","key":"6091_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-022-00545-9","volume":"17","author":"SS Puntambekar","year":"2022","unstructured":"Puntambekar SS, Moutinho M, Lin PB, Jadhav V, Tumbleson-Brink D, Balaji A et al (2022) CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u2019s disease. Mol Neurodegener 17(1):47. https:\/\/doi.org\/10.1186\/s13024-022-00545-9","journal-title":"Mol Neurodegener"},{"issue":"3","key":"6091_CR88","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, Colonna M (2018) Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med 215(3):745\u2013760. https:\/\/doi.org\/10.1084\/jem.20171529","journal-title":"J Exp Med"},{"issue":"1","key":"6091_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS et al (2018) The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease. Mol Neurodegener 13(1). https:\/\/doi.org\/10.1186\/s13024-018-0262-8","journal-title":"Mol Neurodegener"},{"issue":"2","key":"6091_CR90","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91(2):328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"issue":"4","key":"6091_CR91","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM et al (2016) TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90(4):724\u2013739. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.003","journal-title":"Neuron"},{"issue":"6","key":"6091_CR92","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","volume":"10","author":"CF Slattery","year":"2014","unstructured":"Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J et al (2014) R47H TREM2 variant increases risk of typical early-onset Alzheimer\u2019s disease but not of prion or frontotemporal dementia. Alzheimers Dement 10(6):602-608.e4. https:\/\/doi.org\/10.1016\/j.jalz.2014.05.1751","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6091_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M H\u00fcttenrauch","year":"2018","unstructured":"H\u00fcttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S et al (2018) Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun 6(1). https:\/\/doi.org\/10.1186\/s40478-018-0612-3","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"6091_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115343","volume":"44","author":"M Liu","year":"2025","unstructured":"Liu M, Zhu J, Zheng J, Han X, Jiang L, Tong X et al (2025) GPNMB and ATP6V1A interact to mediate microglia phagocytosis of multiple types of pathological particles. Cell Rep 44(3). https:\/\/doi.org\/10.1016\/j.celrep.2025.115343","journal-title":"Cell Rep"},{"issue":"22","key":"6091_CR95","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G et al (2022) SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185(22):4135-4152.e22. https:\/\/doi.org\/10.1016\/j.cell.2022.09.030","journal-title":"Cell"},{"issue":"5","key":"6091_CR96","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y et al (2018) TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron 97(5):1023-1031.e7. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.031","journal-title":"Neuron"},{"issue":"7","key":"6091_CR97","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1007\/s12035-025-04801-z","volume":"62","author":"N Li","year":"2025","unstructured":"Li N, Wang B, Wang Y, Tian X, Lin J, Sun X et al (2025) Exercise ameliorates dysregulated mitochondrial fission, mitochondrial respiration, and neuronal apoptosis in Parkinson\u2019s disease mice via the Irisin\/AMPK\/SIRT1 pathway. Mol Neurobiol 62(7):8843\u20138856. https:\/\/doi.org\/10.1007\/s12035-025-04801-z","journal-title":"Mol Neurobiol"},{"key":"6091_CR98","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.18632\/oncotarget.23640","volume":"9","author":"AU Joshi","year":"2018","unstructured":"Joshi AU, Saw NL, Shamloo M, Mochly-Rosen D (2018) Drp1\/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer\u2019s disease. Oncotarget 9:6128\u20136143. https:\/\/doi.org\/10.18632\/oncotarget.23640","journal-title":"Oncotarget"},{"issue":"3","key":"6091_CR99","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/revneuro-2022-0056","volume":"34","author":"W Shi","year":"2022","unstructured":"Shi W, Tan C, Liu C, Chen D (2022) Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases. Rev Neurosci 34(3):275\u2013294. https:\/\/doi.org\/10.1515\/revneuro-2022-0056","journal-title":"Rev Neurosci"},{"issue":"11","key":"6091_CR100","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1021\/acs.jmedchem.3c00555","volume":"66","author":"OA Lambourne","year":"2023","unstructured":"Lambourne OA, Bell S, Wilhelm LP, Yarbrough EB, Holly GG, Russell OM et al (2023) PINK1-dependent mitophagy inhibits elevated ubiquitin phosphorylation caused by mitochondrial damage. J Med Chem 66(11):7645\u20137656. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00555","journal-title":"J Med Chem"},{"issue":"15","key":"6091_CR101","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4544","volume":"7","author":"CM Hung","year":"2021","unstructured":"Hung CM, Lombardo PS, Malik N, Brun SN, Hellberg K, Van Nostrand JL et al (2021) AMPK\/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy. Sci Adv 7(15). https:\/\/doi.org\/10.1126\/sciadv.abg4544","journal-title":"Sci Adv"},{"issue":"5","key":"6091_CR102","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/jnc.15058","volume":"155","author":"Y Tang","year":"2020","unstructured":"Tang Y, Le W (2020) Aberrant Drp1 phosphorylation in neurodegenerative diseases. J Neurochem 155(5):472\u2013485. https:\/\/doi.org\/10.1111\/jnc.15058","journal-title":"J Neurochem"},{"issue":"7","key":"6091_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413451","volume":"12","author":"M Xiong","year":"2025","unstructured":"Xiong M, Xia D, Yu H, Meng L, Zhang X, Chen J et al (2025) Microglia process \u03b1-synuclein fibrils and enhance their pathogenicity in a TREM2-dependent manner. Adv Sci (Weinh) 12(7). https:\/\/doi.org\/10.1002\/advs.202413451","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"6091_CR104","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41380-023-02239-0","volume":"28","author":"J Yao","year":"2023","unstructured":"Yao J, Wang Z, Song W, Zhang Y (2023) Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol Psychiatry 28(11):4512\u20134527. https:\/\/doi.org\/10.1038\/s41380-023-02239-0","journal-title":"Mol Psychiatry"},{"issue":"7","key":"6091_CR105","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awab122","volume":"144","author":"Y Xia","year":"2021","unstructured":"Xia Y, Zhang G, Kou L, Yin S, Han C, Hu J et al (2021) Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2. Brain 144(7):2024\u20132037. https:\/\/doi.org\/10.1093\/brain\/awab122","journal-title":"Brain"},{"issue":"7","key":"6091_CR106","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/glia.24531","volume":"72","author":"R Barreto-N\u00fa\u00f1ez","year":"2024","unstructured":"Barreto-N\u00fa\u00f1ez R, B\u00e9land LC, Boutej H, Picher-Martel V, Dupr\u00e9 N, Barbeito L et al (2024) Chronically activated microglia in ALS gradually lose their immune functions and develop unconventional proteome. Glia 72(7):1319\u20131339. https:\/\/doi.org\/10.1002\/glia.24531","journal-title":"Glia"},{"issue":"1","key":"6091_CR107","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41593-021-00975-6","volume":"25","author":"M Xie","year":"2022","unstructured":"Xie M, Liu YU, Zhao S, Zhang L, Bosco DB, Pang YP et al (2022) TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci 25(1):26\u201338. https:\/\/doi.org\/10.1038\/s41593-021-00975-6","journal-title":"Nat Neurosci"},{"issue":"1","key":"6091_CR108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00401-025-02913-3","volume":"150","author":"JF Tuddenham","year":"2025","unstructured":"Tuddenham JF, Fujita M, Lee E, Nimmagadda N, Khairallah A, Harbison C et al (2025) Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord. Acta Neuropathol 150(1):10. https:\/\/doi.org\/10.1007\/s00401-025-02913-3","journal-title":"Acta Neuropathol"},{"issue":"16","key":"6091_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414260","volume":"12","author":"X Li","year":"2025","unstructured":"Li X, Jin S, Wang D, Wu Y, Tang X, Liu Y, Yao T, Han S, Sun L, Wang Y, Hou SX (2025) Accumulation of damaging lipids in the Arf1-ablated neurons promotes neurodegeneration through releasing mtDNA and activating inflammatory pathways in microglia. Adv Sci (Weinh) 12(16). https:\/\/doi.org\/10.1002\/advs.202414260","journal-title":"Adv Sci (Weinh)"},{"key":"6091_CR110","doi-asserted-by":"publisher","first-page":"578411","DOI":"10.1016\/j.jneuroim.2024.578411","volume":"394","author":"H Yadav","year":"2024","unstructured":"Yadav H, Bakshi A, Anamika Singh V, Paul P, Murugan NA et al (2024) Co-localization and co-expression of Olfml3 with Iba1 in brain of mice. J Neuroimmunol 394:578411. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578411","journal-title":"J Neuroimmunol"},{"key":"6091_CR111","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3389\/fimmu.2018.01728","volume":"9","author":"N Neidert","year":"2018","unstructured":"Neidert N, von Ehr A, Z\u00f6ller T, Spittau B (2018) Microglia-specific expression of Olfml3 is directly regulated by transforming growth factor beta1-induced smad2 signaling. Front Immunol 9:1728. https:\/\/doi.org\/10.3389\/fimmu.2018.01728","journal-title":"Front Immunol"},{"issue":"5","key":"6091_CR112","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.7150\/ijbs.103859","volume":"21","author":"Q Yu","year":"2025","unstructured":"Yu Q, Mei H, Gu Q, Zeng R, Li Y, Zhang J et al (2025) OLFML3 promotes IRG1 mitochondrial localization and modulates mitochondrial function in macrophages. Int J Biol Sci 21(5):2275\u20132295. https:\/\/doi.org\/10.7150\/ijbs.103859","journal-title":"Int J Biol Sci"},{"issue":"1","key":"6091_CR113","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H, Dey KK, Chen PC, Li Y, Niu M, Cho JH et al (2020) Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener 15(1):43. https:\/\/doi.org\/10.1186\/s13024-020-00384-6","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6091_CR114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-025-00874-5","volume":"20","author":"JM Yarbro","year":"2025","unstructured":"Yarbro JM, Shrestha HK, Wang Z, Zhang X, Zaman M, Chu M et al (2025) Proteomic landscape of Alzheimer\u2019s disease: emerging technologies, advances and insights (2021\u20132025). Mol Neurodegener 20(1):83. https:\/\/doi.org\/10.1186\/s13024-025-00874-5","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6091_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56853-3","volume":"16","author":"JM Yarbro","year":"2025","unstructured":"Yarbro JM, Han X, Dasgupta A, Yang K, Liu D, Shrestha HK et al (2025) Human and mouse proteomics reveals the shared pathways in Alzheimer\u2019s disease and delayed protein turnover in the amyloidome. Nat Commun 16(1). https:\/\/doi.org\/10.1038\/s41467-025-56853-3","journal-title":"Nat Commun"},{"issue":"1","key":"6091_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56124-1","volume":"16","author":"R Martins-Ferreira","year":"2025","unstructured":"Martins-Ferreira R, Calafell-Segura J, Leal B, Rodr\u00edguez-Ubreva J, Mart\u00ednez-Saez E, Mereu E et al (2025) The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions. Nat Commun 16(1). https:\/\/doi.org\/10.1038\/s41467-025-56124-1","journal-title":"Nat Commun"},{"issue":"14","key":"6091_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144689","volume":"12","author":"J Doroszkiewicz","year":"2023","unstructured":"Doroszkiewicz J, Kulczy\u0144ska-Przybik A, Dulewicz M, Borawska R, Zajkowska M, S\u0142owik A et al (2023) Potential utility of cerebrospinal fluid glycoprotein nonmetastatic melanoma protein B as a neuroinflammatory diagnostic biomarker in mild cognitive impairment and Alzheimer\u2019s disease. J Clin Med 12(14). https:\/\/doi.org\/10.3390\/jcm12144689","journal-title":"J Clin Med"},{"issue":"1","key":"6091_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00828-1","volume":"13","author":"F Aichholzer","year":"2021","unstructured":"Aichholzer F, Klafki HW, Ogorek I, Vogelgsang J, Wiltfang J, Scherbaum N et al (2021) Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther 13(1). https:\/\/doi.org\/10.1186\/s13195-021-00828-1","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"6091_CR119","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1177\/1877718X241288712","volume":"14","author":"XC Zhu","year":"2024","unstructured":"Zhu XC, Mizutani Y, Ohdake R, Tatebe H, Maeda T, Shima S et al (2024) CSF GPNMB in Parkinson\u2019s disease: a potential association with age and microglial activation. J Parkinsons Dis 14(8):1533\u20131542. https:\/\/doi.org\/10.1177\/1877718X241288712","journal-title":"J Parkinsons Dis"},{"issue":"6608","key":"6091_CR120","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk0637","volume":"377","author":"ME Diaz-Ortiz","year":"2022","unstructured":"Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N et al (2022) GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein. Science 377(6608). https:\/\/doi.org\/10.1126\/science.abk0637","journal-title":"Science"},{"key":"6091_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.08.013","volume":"120","author":"EB Moloney","year":"2018","unstructured":"Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ (2018) The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson\u2019s disease patients and increases after lysosomal stress. Neurobiol Dis 120:1\u201311. https:\/\/doi.org\/10.1016\/j.nbd.2018.08.013","journal-title":"Neurobiol Dis"},{"issue":"5","key":"6091_CR122","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/biomedicines11051250","volume":"11","author":"S Oh","year":"2023","unstructured":"Oh S, Jang Y, Na CH (2023) Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics. Biomedicines 11(5):1250. https:\/\/doi.org\/10.3390\/biomedicines11051250","journal-title":"Biomedicines"},{"issue":"1","key":"6091_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00657-w","volume":"18","author":"I Pes\u00e4maa","year":"2023","unstructured":"Pes\u00e4maa I, M\u00fcller SA, Robinson S, Darcher A, Paquet D, Zetterberg H et al (2023) A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer\u2019s disease patients from controls. Mol Neurodegener 18(1). https:\/\/doi.org\/10.1186\/s13024-023-00657-w","journal-title":"Mol Neurodegener"},{"issue":"7","key":"6091_CR124","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/jnc.16078","volume":"168","author":"K Kawahara","year":"2024","unstructured":"Kawahara K, Hasegawa T, Hasegawa N, Izumi T, Sato K, Sakamaki T et al (2024) Truncated GPNMB, a microglial transmembrane protein, serves as a scavenger receptor for oligomeric \u03b2-amyloid peptide1-42 in primary type 1 microglia. J Neurochem 168(7):1317\u20131339. https:\/\/doi.org\/10.1111\/jnc.16078","journal-title":"J Neurochem"},{"issue":"6","key":"6091_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115777","volume":"44","author":"AM Lish","year":"2025","unstructured":"Lish AM, Ashour N, Pearse RV 2nd, Galle PC, Orme GA, Heuer SE et al (2025) Astrocyte induction of disease-associated microglia is suppressed by acute exposure to fAD neurons in human iPSC triple cultures. Cell Rep 44(6). https:\/\/doi.org\/10.1016\/j.celrep.2025.115777","journal-title":"Cell Rep"},{"issue":"2","key":"6091_CR126","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J (2023) Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7FAD mice. Nat Aging 3(2):202\u2013212. https:\/\/doi.org\/10.1038\/s43587-022-00337-2","journal-title":"Nat Aging"},{"issue":"5","key":"6091_CR127","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.7150\/ijbs.91543","volume":"20","author":"NS Yang","year":"2024","unstructured":"Yang NS, Zhong WJ, Sha HX, Zhang CY, Jin L, Duan JX, Xiong JB, You ZJ, Zhou Y, Guan CX (2024) mtDNA-cGAS-STING axis-dependent NLRP3 inflammasome activation contributes to postoperative cognitive dysfunction induced by sevoflurane in mice. Int J Biol Sci 20(5):1927\u20131946. https:\/\/doi.org\/10.7150\/ijbs.91543","journal-title":"Int J Biol Sci"},{"key":"6091_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860977","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong L, Li W, Chang E, Wang W, Shen N, Xu X, Wang X, Zhang Y, Sun W, Hu W, Xu P, Liu X (2022) mtDNA-STING axis mediates microglial polarization via IRF3\/NF-\u03baB signaling after ischemic stroke. Front Immunol 13","journal-title":"Front Immunol"},{"issue":"12","key":"6091_CR129","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/d41573-023-00185-8","volume":"22","author":"A Mullard","year":"2023","unstructured":"Mullard A (2023) Biotechs step on cGAS for autoimmune diseases. Nat Rev Drug Discov 22(12):939\u2013941. https:\/\/doi.org\/10.1038\/d41573-023-00185-8","journal-title":"Nat Rev Drug Discov"},{"key":"6091_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156928","volume":"145","author":"M Guo","year":"2025","unstructured":"Guo M, Wang Z, Zhou X, Yu C, Wu J, Yu L et al (2025) Ciliatoside A attenuates neuroinflammation in Alzheimer\u2019s disease by activating mitophagy and inhibiting NLRP3 inflammasome activation. Phytomedicine 145. https:\/\/doi.org\/10.1016\/j.phymed.2025.156928","journal-title":"Phytomedicine"},{"issue":"8","key":"6091_CR131","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17(8):588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"6091_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s44400-025-00011-5","volume":"1","author":"A Auger","year":"2025","unstructured":"Auger A, Faidi R, Rickman AD, Martinez CP, Fajfer A, Carling J, Hilyard H, Ali M, Ono R, Cleveland C, Seliniotakis R, Truong N, Chefson A, Raymond M, Germain MA, Crackower MA, Heckmann BL (2025) Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. NPJ Dement 1(1). https:\/\/doi.org\/10.1038\/s44400-025-00011-5","journal-title":"NPJ Dement"},{"issue":"10","key":"6091_CR133","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/mds.30307","volume":"40","author":"N Clarke","year":"2025","unstructured":"Clarke N, Thornton P, Reader V, Lindsay N, Digby Z, Mullen B, Gorman M, Jacobson E, Langdon G, Johnstone H, Wheeler A, Watt AP (2025) Anti-neuroinflammatory and anti-inflammatory effects of the NLRP3 inhibitor NT-0796 in subjects with Parkinson\u2019s disease. Mov Disord 40(10):2199\u20132208. https:\/\/doi.org\/10.1002\/mds.30307","journal-title":"Mov Disord"},{"key":"6091_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190219","volume":"14","author":"ML Cl\u00e9net","year":"2023","unstructured":"Cl\u00e9net ML, Keaney J, Gillet G, Valadas JS, Langlois J, Cardenas A, Gasser J, Kadiu I (2023) Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1190219","journal-title":"Front Immunol"},{"issue":"2","key":"6091_CR135","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85(2):257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"issue":"6","key":"6091_CR136","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Xue NJ et al (2023) Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease. Aging Cell 22(6). https:\/\/doi.org\/10.1111\/acel.13834","journal-title":"Aging Cell"},{"issue":"3","key":"6091_CR137","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA et al (2017) Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms. Trends Neurosci 40(3):151\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2017.01.002","journal-title":"Trends Neurosci"},{"issue":"7","key":"6091_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073330","volume":"22","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A, Sharifzad F, Yasavoli-Sharahi H, Lorzadeh S et al (2021) Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci 22(7). https:\/\/doi.org\/10.3390\/ijms22073330","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6091_CR139","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46(4):329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"6091_CR140","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/s44321-025-00323-2","volume":"17","author":"A Li","year":"2025","unstructured":"Li A, Huang S, Cao SQ, Lin J, Zhao L, Yu F, Huang M, Yang L, Xin J, Wen J, Yan L, Zhang K, Jiang M, Le W, Li P, Liu YU, Qin D, Lu J, Lu G, Shen H, Yao X, Fang EF, Su H (2025) Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy. EMBO Mol Med 17(11):3139\u20133173. https:\/\/doi.org\/10.1038\/s44321-025-00323-2","journal-title":"EMBO Mol Med"},{"issue":"3","key":"6091_CR141","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41593-022-01240-0","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI et al (2023) A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci 26(3):416\u2013429. https:\/\/doi.org\/10.1038\/s41593-022-01240-0","journal-title":"Nat Neurosci"},{"issue":"4","key":"6091_CR142","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D et al (2020) Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med 12(4). https:\/\/doi.org\/10.15252\/emmm.201911227","journal-title":"EMBO Mol Med"},{"issue":"9","key":"6091_CR143","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S, Ibrahim A, Rhinn H, Tassi I, Rosenthal A, Schwabe T, Colonna M (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med 217(9). https:\/\/doi.org\/10.1084\/jem.20200785","journal-title":"J Exp Med"},{"issue":"1","key":"6091_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01599-1","volume":"16","author":"H Long","year":"2024","unstructured":"Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, Yeh F, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A (2024) Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease. Alzheimers Res Ther 16(1). https:\/\/doi.org\/10.1186\/s13195-024-01599-1","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"6091_CR145","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41593-022-01240-0","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M, Hummel S, Lianoglou S, Pizzo ME, Prorok R, Thomsen E, Bartos LM, Beumers P, Capell A, Davis SS, de Weerd L, Dugas JC, Duque J, Earr T, Gadkar K, Giese T, Gill A, Gn\u00f6rich J, Ha C, Kannuswamy M, Kim DJ, Kunte ST, Kunze LH, Lac D, Lechtenberg K, Leung AW, Liang CC, Lopez I, McQuade P, Modi A, Torres VO, Nguyen HN, Pes\u00e4maa I, Propson N, Reich M, Robles-Colmenares Y, Schlepckow K, Slemann L, Solanoy H, Suh JH, Thorne RG, Vieira C, Wind-Mark K, Xiong K, Zuchero YJY, Diaz D, Dennis MS, Huang F, Scearce-Levie K, Watts RJ, Haass C, Lewcock JW, Di Paolo G, Brendel M, Sanchez PE, Monroe KM (2023) A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci 26(3):416\u2013429. https:\/\/doi.org\/10.1038\/s41593-022-01240-0","journal-title":"Nat Neurosci"},{"issue":"1","key":"6091_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J (2021) Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflammation 18(1). https:\/\/doi.org\/10.1186\/s12974-020-01980-5","journal-title":"J Neuroinflammation"},{"issue":"10","key":"6091_CR147","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s42255-022-00643-4","volume":"4","author":"L Leng","year":"2022","unstructured":"Leng L, Yuan Z, Pan R, Su X, Wang H, Xue J et al (2022) Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to \u03b2-amyloid clearance. Nat Metab 4(10):1287\u20131305. https:\/\/doi.org\/10.1038\/s42255-022-00643-4","journal-title":"Nat Metab"},{"issue":"7","key":"6091_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114488","volume":"43","author":"JF Codocedo","year":"2024","unstructured":"Codocedo JF, Mera-Reina C, Bor-Chian Lin P, Fallen PB, Puntambekar SS, Casali BT, Jury-Garfe N, Martinez P, Lasagna-Reeves CA, Landreth GE (2024) Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer\u2019s progression. Cell Rep 43(7). https:\/\/doi.org\/10.1016\/j.celrep.2024.114488","journal-title":"Cell Rep"},{"key":"6091_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105605","volume":"163","author":"J Li","year":"2022","unstructured":"Li J, Chen L, Qin Q, Wang D, Zhao J, Gao H, Yuan X, Zhang J, Zou Y, Mao Z, Xiong Y, Min Z, Yan M, Wang CY, Xue Z (2022) Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease. Neurobiol Dis 163. https:\/\/doi.org\/10.1016\/j.nbd.2021.105605","journal-title":"Neurobiol Dis"},{"issue":"17","key":"6091_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/cells14171387","volume":"14","author":"L Li","year":"2025","unstructured":"Li L, Zheng X, Ma H, Zhu M, Li X, Sun X, Feng X (2025) TREM2 in neurodegenerative diseases: mechanisms and therapeutic potential. Cells 14(17). https:\/\/doi.org\/10.3390\/cells14171387","journal-title":"Cells"},{"key":"6091_CR151","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Ranjan Panda S, Murty USN, Naidu VGM (2021) Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav Immun 91:142\u2013158. https:\/\/doi.org\/10.1016\/j.bbi.2020.09.017","journal-title":"Brain Behav Immun"},{"key":"6091_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156482","volume":"139","author":"Y Qi","year":"2025","unstructured":"Qi Y, Zhang J, Zhang Y, Zhu H, Wang J, Xu X, Jin S, Wang C, Zhang F, Zhao M, Wu Z, Zhu H, Yan P (2025) Curcuma wenyujin extract alleviates cognitive deficits and restrains pyroptosis through PINK1\/Parkin mediated autophagy in Alzheimer\u2019s disease. Phytomedicine 139. https:\/\/doi.org\/10.1016\/j.phymed.2025.156482","journal-title":"Phytomedicine"},{"key":"6091_CR153","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bioactmat.2025.06.029","volume":"52","author":"M Fei","year":"2025","unstructured":"Fei M, Liu Q, Zhang H, Du Y, Chen L, Wang J et al (2025) Three-stage sequential targeted nasal drops for correcting abnormal mitochondrial division in microglia. Bioact Mater 52:810\u2013828. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.06.029","journal-title":"Bioact Mater"},{"issue":"1","key":"6091_CR154","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12951-025-03911-z","volume":"24","author":"MY Shie","year":"2025","unstructured":"Shie MY, Chen MC, Chen Y, Huang SW, Lin YH, Yu MH et al (2025) Engineered extracellular vesicles-mediated curcumin delivery in brain microenvironment modulating lysosomes, mitochondria, and microglia reprogram for Parkinson\u2019s disease therapy. J Nanobiotechnology 24(1):46. https:\/\/doi.org\/10.1186\/s12951-025-03911-z","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"6091_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00355","volume":"21","author":"H Eo","year":"2024","unstructured":"Eo H, Yu SH, Choi Y, Kim Y, Kang YC, Lee H et al (2024) Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson\u2019s disease. Neurotherapeutics 21(4). https:\/\/doi.org\/10.1016\/j.neurot.2024.e00355","journal-title":"Neurotherapeutics"},{"issue":"2","key":"6091_CR156","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3233\/JAD-190853","volume":"72","author":"K Nitzan","year":"2019","unstructured":"Nitzan K, Benhamron S, Valitsky M, Kesner EE, Lichtenstein M, Ben-Zvi A et al (2019) Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer\u2019s disease mice. J Alzheimers Dis 72(2):587\u2013604. https:\/\/doi.org\/10.3233\/JAD-190853","journal-title":"J Alzheimers Dis"},{"key":"6091_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114268","volume":"159","author":"R Jain","year":"2023","unstructured":"Jain R, Begum N, Tryphena KP, Singh SB, Srivastava S, Rai SN et al (2023) Inter and intracellular mitochondrial transfer: future of mitochondrial transplant therapy in Parkinson\u2019s disease. Biomed Pharmacother 159. https:\/\/doi.org\/10.1016\/j.biopha.2023.114268","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6091_CR158","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1038\/s41467-025-58189-4","volume":"16","author":"SJ Li","year":"2025","unstructured":"Li SJ, Zheng QW, Zheng J, Zhang JB, Liu H, Tie JJ et al (2025) Mitochondria transplantation transiently rescues cerebellar neurodegeneration improving mitochondrial function and reducing mitophagy in mice. Nat Commun 16(1):2839. https:\/\/doi.org\/10.1038\/s41467-025-58189-4","journal-title":"Nat Commun"},{"issue":"7","key":"6091_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071006","volume":"12","author":"S Sweetat","year":"2023","unstructured":"Sweetat S, Nitzan K, Suissa N, Haimovich Y, Lichtenstein M, Zabit S et al (2023) The beneficial effect of mitochondrial transfer therapy in 5XFAD mice via liver-serum-brain response. Cells 12(7). https:\/\/doi.org\/10.3390\/cells12071006","journal-title":"Cells"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06091-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06091-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06091-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:32:25Z","timestamp":1785583945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06091-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6091"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06091-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript for publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"800"}}